Catalyst Pharmaceuticals, Inc.
CPRXNASDAQ
Healthcare
Biotechnology
$24.70
-0.12(-0.5%)
52W $19.13 – $26.31
Quick:
SCHEDULE 13G/A
Mar 26, 2026 (1 weeks ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K/A
Mar 18, 2026 (2 weeks ago)Current Report (Amendment)
Material event disclosure
Event materiality and market reaction
10-K
Feb 25, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Feb 25, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 12, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Nov 10, 2025 (4 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Nov 5, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 5, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Oct 1, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K/A
Aug 28, 2025 (7 months ago)Current Report (Amendment)
Material event disclosure
Event materiality and market reaction
8-K
Aug 25, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 7, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 6, 2025 (8 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Aug 6, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 4, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 2, 2025 (10 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
May 23, 2025 (10 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
May 7, 2025 (11 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
May 7, 2025 (11 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13G/A
Apr 28, 2025 (11 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active